Introduction
Chronic kidney disease (CKD) is a serious public health problem, which could lead to end-stage renal disease (ESRD) and increased cardiovascular morbidity and mortality (1) . CKD affects 10% to 16% of adults around the world (2) . CKD is usually asymptomatic until later stages and accurate prevalence data are lacking (3) . The factors race, age, gender and serum creatinine are used for the computation of estimated glomerular filtration rate (eGFR) to determine the stages of CKD patient. Other prognostic factors such as urea, albumin, hemoglobin, body mass index along with concurrent diseases such as hypertension and diabetes are traditionally or nontraditionally are associated with CKD.
Hsu et al applied survival analysis to evaluate factors associated with time to an event of interest (e.g., ESRD and mortality) among CKD populations (4). Roy et al fitted three logistic regression models of progressive CKD. Age, sex, and race were taken as the predictors for the first model. The second model included GFR and proteinuria along with the predictors of first model. In the third model, they included other predictors; angiotensin II receptor blocker, an indicator for any history of cardiovascular disease, diabetes, educational level, systolic blood pressure, and body mass index (5) .
In recent years, there is a considerable increase in research and applications related to permutation tests (6) . It has been used in clinical trials, functional data analysis, spatial statistics, principal component analysis, shape analysis, survival analysis and many other fields (7) (8) (9) (10) (11) (12) (13) . Galimberti et al have applied multivariate permutation test with simulations for the comparison of bone marrow transplantation and chemotherapy in the treatment of pediatric leukemia (14) . Giancristofaro et al compared the sampling heterogeneity of a categorical variable X in two populations using permutation test (15) . In practice, a large number of problems may also be solved effectively and usefully by applying traditional parametric methods (likelihood-based) or nonparametric methods (rankbased). Although in relatively mild conditions their permutation counterparts are generally asymptotically as good as the best ones (16) .
Objectives
The main objective of this paper is a hypothesis testing, in which the null hypothesis specifies no difference between groups, is an important tool in the assessment of new medical interventions. We have used the parametric and non-parametric tests for assessing the role of prognostic factors in comparison of two populations for the progression of the disease. Firstly likelihood ratio test is applied to compare (i) stage 2 and stage 3 (ii) stage 3 and stage 4 with respect to each factor because of the applicability of the test in every distribution ( continuous and discrete). To apply the likelihood ratio test, an appropriate distribution based on AIC value is fitted to the available data set. Secondly, we applied the permutation test for the same population as an alternative tool to see the consistency of the result obtained from the likelihood ratio test. The correspondence between parametric and permutation test results gives confidence that the results are stable and reliable (17) and are able to identify the role of prognostic factors in the progression of disease stage wise. The test has been applied to a data set of 100 CKD outpatients with varying health conditions. The paper intends to evaluate the differences in the impact of prognostic factors for the progression of CKD into higher stages using parametric and non parametric tests. We aimed to determine the factors other than the parameters as age, gender, race, and serum creatinine, used in computation of eGFR to assess the health of CKD patients with respect to their stage using the results of appropriate tests.
Patients and Methods

Likelihood ratio test
The prognostic factors for the progression of CKD under consideration are age, sex, diabetes, hypertension, serum creatinine, urea, hemoglobin, body mass index and albumin. Let, there are three sets or groups of data consisting of n 1 , n 2 and n 3 observations corresponding to three stages of CKD like, stage 2, stage 3 and stage 4 respectively. The observations are denoted by , i=1,2,...,n ; j=1,2,3; k=1,2,...,9 ijk j X . i indexes the patient number, j indexes the group number and k indexes the prognostic factor (1 age, 2 sex, 3 diabetes, 4 hypertension, 5 serum creatinine, 6 urea, 7 hemoglobin, 8 body mass index, 9 albumin) X ijk indicates the value of the k th factor for the i th patient of the j th group. The best fitted distribution is obtained by AIC value of the distributions for each factor. The probability function and log likelihood function of X ijk 's under various distribution are given as
i= 1,2,...,n ; j=1,2,3; k=1;
..,n ; 1, 2,3;
i=1,2,...,n ; 1, 2,3; 9; 0; 0; 0. 
We aimed to compare the two populations (i) group 1 and group 2 and (ii) group 2 and group 3 under each variable. One of the methods to accomplish the task is likelihood ratio test. In likelihood ratio test, the maximum likelihood estimates of unknown parameters are obtained by solving the likelihood equations simultaneously for each population. Likelihood equations are formed by partially differentiating the log likelihood function with respect to unknown parameters and are equated to zero. We also obtain the maximum likelihood estimates of unknown parameters of the combined population under null hypothesis.
For example the two Weibull populations corresponding to two groups (group 1 and group 2) can be compared using likelihood ratio test as; . Where γ and λ are unknown.
The log likelihood of the combined group under H 0 is given by
The maximum likelihood estimates of unknown parameters are 1 λ  and 1 γ for group 1, 2 λ  and 2 γ for group 2 and λ  and γ for combined group. We compute the test statistic
and it follows chi-square distribution with two degrees of freedom.
Similarly the log likelihood of combined group under H 0 for lognormal distribution, gamma distribution, normal distribution and Bernoulli distribution are given by
The likelihood test for the comparison of two populations under lognormal, gamma, normal and Bernoulli distributions can be applied as explained in Weibull distribution.
Permutation test
Our objective is to compare the two populations (i) group 1 and group 2 and (ii) group 2 and group 3 under each variable. When a parametric form of underlying distribution is not specified, permutation test also known as randomization test is widely used as practice in nonparametric statistics because of minimal assumptions and flexibility of the test statistic. Permutation tests can be applied to continuous, ordinal or categorical data from normal as well as non-normal distribution. Permutation methods can still be applied even when a parametric statistical method fails (18) . There is a relaxation in choosing a test statistic.
Let there are n 1 observations of the prognostic factor corresponding to one stage and n 2 observations corresponding to other stage. The null hypothesis is that there is no significant difference between the effects of prognostic factor in two different stages. The only assumption in permutation test is that the distribution of prognostic factor under the null hypothesis is same in both the stages and being tested. Under the null hypothesis any particular permutation of the observations between the two stages has the same probability to occur as any other permutation. The steps involved for permutation test are summarized as follows:
Step 1: Compute the difference between the mean of the observed data corresponding to two stages and denote it by D obs .
Step 2: Form a vector of n 1 + n 2 observations.
Step 3: Permute n 1 + n 2 observations between the two stages and assign n 2 observations to one stage and n 2 observations to other stage.
Step 4: Consider all possible permutations
for small sample sizes and a pre determined number of random sample of permutations for large sample sizes.
Step 5: Calculate the difference between the mean of one stage and other stage for each permutation under consideration and denote it by D.
Step 6: For right tailed test P value is computed as the proportion of D greater than or equal to D obs . The mathematical formula for computing P value is
Step 7: Reject the null hypothesis at α level of significance if P value is less than or equal to α.
Depending upon the situation, one can choose the test statistic. Instead of difference of means the other test statistics can be difference of medians.
Ethical issues
The research followed the tenets of the Declaration of Helsinki.
Results
Data description
The data consists of 100 non-hospitalized CKD patients. This data comprise of three stages of CKD patients namely stage 2, stage 3 and stage 4 having 20, 37 and 43 number of patients respectively. The data corresponds to the variables age, sex, diabetes, hypertension, serum creatinine (SrCr), urea, hemoglobin (Hb), body mass index (BMI) and albumin (Alb) for each stage. Stage wise number of male patients and female patients along with diabetes and hypertension status are shown in Table 1 . Table 2 shows the descriptive statistics corresponding to continuous variables for each stage. Table 4 and Table 5 .
Application of likelihood ratio test
Permutation test
There are two broad approaches to compare the We have also computed the mean difference between two sets of observations after permuting the 57 observations into two stages consisting of 20 observations in stage 2 and 37 observations in stage 3. The value of test statistic using the mean differences of original sets of data and permuted sets of data under two groups is computed for each variable and corresponding P value of the test is obtained. The mean difference of original sets of observations, the value of test statistic and P value are shown in Table 6 . The similar procedure has been adopted for comparison of stage 3 population and stage 4 population. The mean difference of original sets of observations, the value of test statistic and P value for permutation test are shown in Table 6 and Table 7 . Table 8 and Table 9 .
Power curves of the permutation test and likelihood Figure 1 and Figure 2 , for each variable.
Discussion
CKD is recognized as having changed from a subspecialty issue to a global health concern (1). Identification of factors predisposing an individual to CKD is important not only in terms of personal but also from community health point of view as some risk factors can be modified and thereby preventing or slow downing the progression of disease to end stage renal disease. Economic burden of disease can be reduced by early intervention According to NKF, eGFR is computed on the basis of age, sex, and race and also serum creatinine. Likelihood ratio test though very commonly used test but is highly recommended and is applicable for both continuous and discrete distribution. In practice, parametric methods require a set of stringent assumptions which are difficult to justify and are quite unrealistic and unclear and seldom met. In such situations, nonparametric tests are more appropriate than parametric counterparts. The relative risk of efficiency of nonparametric method is very small under the applicability of both the tests (19) . The permutation tests are based on more realistic foundations, are intrinsically robust with credible inferences. Permutation tests are successful in many cases where parametric tests fail. As a rule, the test involving fewer assumptions and limitations will have wider applications. Permutation tests require minimum conditions and provide flexibility in selection of test statistics and are independent of distribution. They are widely used test. Permutation test falls under the conditional method of inference and can be treated a test of an exact nonparametric nature in a conditional context. Under the hypothesis of no difference for underlying population distribution, the condition is being made on the pooled observed data in the form of a set of sufficient statistics (20) . Permutation test and likelihood ratio tests suggest that serum creatinine and age are significant factors for the progression of CKD in both from (i) stage 2 to stage 3 and (ii) stage 3 to stage 4. The result has been obtained from our data set and is consistent with the simulation study as well. The power of the permutation test and likelihood ratio test is 1 from the simulation data and has been shown in Table 8 and Table 9 .
Sex of a patient is a non significant factor for the progression of the disease from (i) stage 2 to stage 3 and (ii) stage 3 to stage 4 as revealed by permutation test and likelihood ratio test applied on our data set. However, power We have not considered the factor race of the patient as data of the CKD patients have been collected from the India only.
Apart from the factors considered for the computation of eGFR, some other factors are also responsible for the progression of the disease into severe stages. In our study the factors urea. Hemoglobin and albumin are also coming out to be significant factors for the progression of disease in both (i) stage 2 to stage 3 and (ii) stage 3 to stage 4 by both permutation test and likelihood ratio test. Simulation study also supports this fact as the power associated with the tests is almost unity.
Permutation test and likelihood ratio test based on our data set suggest that body mass index is not a significant factor for the progression of disease towards severity. The simulation study suggests the powers of the permutation test and likelihood ratio test corresponding to the estimated scale parameters of the data set are 0.1 and 0.09 respectively for the comparison of stage 2 and stage 3 and are 0.075 and 0.06 for stage 3 and stage 4. However simulation study also suggests that if the difference between the scale parameters are .06 for (i) stage 2 and stage 3 and (ii) stage 3 and stage 4 then body mass index will be a significant factor the progression of the disease and the power of the test in this case will be approximately 0.99.
Diabetes is a non significant factor as suggested by both permutation test and likelihood ratio test based on the data set for both (i) stage 2 and stage 3 and (ii) stage 3 and stage 4. However the simulation study result is totally in contrast with the data set result. The simulation study based on power of the permutation test and likelihood ratio test suggests that diabetes is a significant factor for the progression of disease from (i) stage 2 to stage 3 and (ii) stage 3 to stage 4. One of the possible reason can be data set is too small and is a single sample where as in simulation study the data set is quite large and the number of sample sets are also very large.
Hyper tension is coming out to be a significant factor for the progression of disease from stage 3 to stage 4 but is a non significant factor for the progression from stage 2 to stage 3. However, according to simulation study hyper tension is a significant factor for the progression of disease. The power associated with the permutation test and likelihood ratio test is almost one.
Conclusion
There exists a statistical significant relationship between the prognostic factors serum creatinine, body mass index, urea, hemoglobin, albumin, age, sex, diabetes, hypertension and progression of CKD to higher stages.
Limitations of the study
The total number of subjects under the present study is small which further reduces the size of the sample in each stage of CKD. Most of the patients are from Delhi and its surrounding areas only. We suggest to investigate the other possible risk factors such as family history, socioeconomic status, smoking and nephrotoxins (alcohol and recreational drugs).
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